Sort
82,697 grants matching “vaccine development”
Improving predictive capacity of models for universal influenza vaccine development
$775,342Richard John Webby · St. Jude Children'S Research Hospital · R01 · FY2022 · AI
Cellular and molecular programming of lung resident T cell memory
$775,320Jacob E Kohlmeier · Emory University · R35 · FY2021 · HL
Preclinical development of human CMV vaccines
$775,296Michael A McVoy · Virginia Commonwealth University · R01 · FY2013 · AI
Innate immune mechanisms of virologic control and recovery from flavivirus encephalitis
$775,277Robyn S Klein · Washington University · R56 · FY2020 · AI
Spontaneous and Induced B cell and T cell responses in Alzheimer's Disease
$775,250Marco Colonna · Washington University · R01 · FY2024 · AG
Targeting tonsillar B cells for the induction of effective mucosal immunity to HIV
$775,239James J Kobie · University Of Rochester · R01 · FY2017 · DE
Cellular and molecular programming of lung resident T cell memory
$775,223Jacob E Kohlmeier · Emory University · R35 · FY2022 · HL
Systems-level identification of host determinants of patient outcomes in Lassa fever and Ebola
$775,214Robert F Garry · Scripps Research Institute, The · U19 · FY2019 · AI
Characterization of Genomics and Metabolomics among Individuals Highly-Exposed, but resistant to Mtb Infection
$775,211Neel Rajnikant Gandhi · Emory University · R01 · FY2021 · AI
The Impact of Systemic Immunosuppression on RSV Antibody Generation and Effector Functions After Vaccination
$775,187Andrew Hoover Karaba · Johns Hopkins University · R01 · FY2025 · AI
Antibody-based countermeasures against fentanyl and its analogues
$775,120Marco Pravetoni · University Of Minnesota · U01 · FY2021 · DA
Vector Biological Studies in Leishmaniasis
$775,112David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$775,112David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Efficacy of Oral CMV/SIV Vectors
$775,096Louis J. Picker · Oregon Health & Science University · R01 · FY2015 · DE
Mali International Center for Excellence in Research: Parasitic Infectious Diseases and their Vectors
$775,082Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Cellular and molecular programming of lung resident T cell memory
$775,038Jacob E Kohlmeier · Emory University · R35 · FY2020 · HL
An Expanded Multivalent Vaccine to Prevent MDR Shigella and ETEC Disease
$775,033Eileen M. Barry · University Of Maryland Baltimore · U19 · FY2020 · AI
Factors Contributing To Immune-Enhanced Disease In The Pathogenesis of RSV
$775,000Barney Scott Graham · Niaid Extramural Activities · Z01 · FY2007 · AI
The effect of HIV exposure and infection on immunity to TB in children
$774,996Grace C John-Stewart · University Of Washington · R01 · FY2023 · AI
How antigen exposure shapes the subsequent NK cell response to HIV
$774,994Silke Paust · Jackson Laboratory · R01 · FY2025 · AI
Cooperative Research Partnership for an Amebic Colitis Vaccine
$774,980William A Petri · University Of Virginia · U01 · FY2007 · AI
Pathogenesis and Vaccine Studies Of Simian Immunodeficiency Virus Infection Of Monkeys
$774,959Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
The effect of HIV exposure and infection on immunity to TB in children
$774,910Grace C John-Stewart · University Of Washington · R01 · FY2022 · AI
DNA Vaccine for Seasonal & Pandemic Influenza
$774,843Deborah L. Fuller · University Of Washington · U01 · FY2010 · AI
Cellular and molecular programming of lung resident T cell memory
$774,830Jacob E Kohlmeier · Emory University · R35 · FY2023 · HL